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Background: Platelet activation occurs in patients with allergic inflammation, and platelets can 36 
be activated directly by allergen via an IgE-dependent process. Platelets have been shown to 37 
activate antigen-presenting cells (APCs) such as CD11c
+
 dendritic cells (DCs) in vitro. Whilst 38 
CD11c
+
 DCs are requisite for allergen sensitization, the role of platelets in this process is 39 
unknown.  40 
Objectives: We investigated whether platelets were necessary for allergen sensitization. 41 
Methods: Balb/c mice sensitised to ovalbumin (OVA), were exposed to subsequent aerosolized 42 
allergen (OVA challenge). We analysed lung CD11c
+
 cell activation, co-localization with 43 
platelets, and some other indices of inflammation. The role of platelets at the time of allergen 44 
sensitization was assessed through platelet depletion experiments restricted to the period of 45 
sensitization.  46 
Results: Platelets co-localized with airway CD11c
+
 cells, and this association increased after 47 
allergen sensitization, and after subsequent allergen exposure. Temporary platelet depletion 48 
(>95%) at the time of allergen sensitization led to a suppression of IgE and IL-4 synthesis, and a 49 
decrease in the pulmonary recruitment of eosinophils, macrophages, and lymphocytes after 50 
subsequent allergen exposure. Furthermore, in mice previously depleted of platelets at the 51 
time of sensitization, the recovered platelet population were shown to have reduced 52 
expression of FcɛRI. Pulmonary CD11c
+
 cell recruitment was suppressed in these mice after 53 
allergen challenge, suggesting the migration of CD11c
+ 
cells in vivo may be dependent on direct 54 
platelet recognition of allergen. 55 




Conclusion: Platelets are necessary for efficient host sensitization to allergen. This propagates 56 
the subsequent inflammatory response during secondary allergen exposure, and increases 57 
platelet association with airway CD11c
+
 cells. 58 
 59 
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recruitment, asthma 61 
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Platelet activation in allergic diseases such as asthma, has been reported extensively over the 79 
last 30 years, with evidence of changes in platelet volume, presence of platelet micro-particles, 80 
release of platelet-specific inflammatory mediators, and an increased incidence of circulating 81 
platelet-leukocyte (including eosinophil) complexes, both in patients undergoing spontaneous 82 
asthma attacks or after allergen challenge.
1-4
 Furthermore, platelet activation correlates 83 
strongly to changes in lung function.
4-9
 Various in vivo studies confirm that the activation of 84 
platelets during allergy and asthma plays a central role in  the inflammatory response.
3,10-13
 Of 85 
significance, pulmonary platelet recruitment and accumulation occurs in the lungs, initially via 86 
an IgE-dependent process whereby platelets migrate and enter the extravascular space.
7,14-17
 87 
The significance and temporal nature of allergen-induced activation of platelets, via FcεRI, has 88 
not been established, yet of pertinence to allergy, platelets from patients allergic to 89 
Dermatophagoides pteronyssinus have been shown to be activated directly by the specific 90 
allergen, or by synthetic peptides derived from the allergen, through an IgE dependent 91 
process.
16,18
 Combined, these studies argue for a causal role of platelet activation in asthma and 92 
allergy, and that such activation is not as a consequence of the inflammatory milieu per se. 93 
Furthermore, it has been shown that platelet-derived 5-HT is also important for dendritic cell 94 
(DC) activation during allergic airways inflammation, further supporting a role for platelets, and 95 
suggesting that the activation and migration of platelets induced by allergen might be of 96 
significance or causal to the sensitization process.
19
  97 
Myeloid DCs (mDCs) are thought to be involved very early in the development of asthma by 98 
inducing sensitization to inhaled antigen, and increasingly, mDCs are viewed as essential pro-99 




inflammatory cells that induce effector cytokine production in primed Th2 cells during airway 100 
inflammation.
20-23
 It is therefore of interest that platelet CD40L has recently been reported to 101 
be involved in the promotion of allergic airways inflammation by polarizing Th2 responses after 102 
allergen exposure.
24
 We have previously demonstrated a presence of platelets extra-vascularly 103 
in the lungs of mice before subsequent allergen exposure in allergen-sensitized mice, but the 104 
vast majority of these platelets were attached to a resident undefined mononuclear cell 105 
population, and the relevance of this occurrence has yet to be established.
16
 We hypothesized 106 
that these platelets are a distinct population that had migrated to the lungs as a result of 107 
exposure to allergen (ip injection of ovalbumin, OVA), and that a population of platelets might 108 
therefore be involved in initial sensitization to allergen. Temporally, the occurrence was clearly 109 
unrelated to subsequent aerosolized exposures to allergen (OVA), which drives platelet 110 
migration into the lungs along with recruited leukocytes.
16
 We report here that CD11c
+
 cells (as 111 
a marker for DCs) are decorated with platelets during allergen sensitization, and investigate the 112 
importance of these platelets during the process of allergen sensitization and their interactions 113 
with CD11c
+
 cells, before and during subsequent exposure to aerosolized allergen. These 114 
studies provide a possible role for the specific activation of platelets by allergen from patients 115 










Materials and Methods  122 
Readers are directed to the online supplementary material document for methodology related 123 
to: Blood microsampling, Immunohistochemistry of lungs, Microscopic analysis and lung 124 
morphometry, Flow cytometric analysis of CD11c+ cells and platelets, and: Quantification of 125 
IgE, IL-4, IL-5, and IFN-γ. 126 
 127 
1. Sensitisation of mice to ovalbumin and bronchoalveolar lavage (BAL). 128 
To understand the importance of platelets during allergen sensitization, and subsequent effects 129 
on the inflammatory response after secondary allergen exposure via an aerosol challenge, a 130 
murine model of allergic sensitization and lung inflammation was used where the sensitization 131 
process can be delineated and confined by a defined route of administration (intraperitoneal 132 
route) compared to the more complex situation arising from continual exposure to allergen via 133 
the airways. All studies were carried out under the Animals (Scientific Procedures) Act of 1986, 134 
and amendments 2012 (United Kingdom) with local ethical approval from King’s College, 135 
London. Studies and reporting have been undertaken under the ARRIVE guidelines. Female 136 
Balb/c mice (20-25g; Harlan UK), housed under standard husbandry conditions of 12 hour 137 
light/dark cycle, 21-23⁰C, in groups of 4-6 animals per cage with access to pelleted chow diet 138 
and water ad libitum, were randomly assigned to different treatment groups. Mice were 139 
sensitised with chicken egg ovalbumin (OVA, grade V, Sigma-Aldrich; 10µg/0.4ml, absorbed in a 140 
saturated solution of an adjuvant: aluminium hydroxide, 0.1M, Sanofi Winthrop), or received 141 




adjuvant only (sham-sensitized mice), intraperitoneally (i.p.) on days 0 and 7. On days 15, 16, 142 
and 17, mice were subsequently nebulised with OVA (10mg/ml) for 30 minutes, 24 hours post 143 
final allergen challenge (day 18).  BAL fluid was processed for total and differential cell counts, 144 
and the enumeration of cytokines, whilst blood was processed for measurement of total IgE 145 
content as previously described.
10,25
 Some groups of mice were sacrificed 0, 24, and 48h after 146 
one day of allergen exposure on day 15, and lungs taken for histological analysis. Groups of 147 
mice were also sacrificed on day 15 in the absence of allergen exposure for measurement of 148 
platelet FcɛRI expression from circulating blood, and (day 15: absence of allergen challenge, day 149 
16, 24 hours post day 15 allergen challenge) for enumeration of CD11c+ cells in lung 150 
homogenates.   151 
 152 
2. Platelet depletion  153 
In order to produce profound, yet temporary, platelet depletion for the selective period of 154 
allergen sensitization, groups of mice were administered intra-muscularly (i.m. 50µL into a 155 
hindlimb) with 25µg/mouse anti-platelet antibody (anti GP1bα, Emfret Technologies) or control 156 
IgG (monoclonal 2A3 anti-trinitrophenol, BioXCell) 24h prior to allergen sensitizations on days -157 
1 and 6. Previous studies in our laboratory have demonstrated that mice receiving this 158 
antiplatelet antibody do not display pulmonary oedema, haemorrhage, or weight loss beyond 159 
10% body weight.  160 
 161 
3. Statistical Analysis 162 




The experimenters were blinded to the identity of experimental groups for the manual 163 
quantification of tissue samples/ cells. Data from allergic animal studies are presented as mean 164 
± standard error of the mean (SEM), and analysed by one-way ANOVA, followed by Bonferroni’s 165 





















 cell and platelet co-localisation occurs in the airways during sensitization to allergen. 181 
 182 
Platelets, in low numbers, have previously been observed adjacent to mononuclear cells in 183 
lungs of mice before allergen exposure.
16
 To identify these cells, and to quantify the extent of 184 
platelet decoration, lung sections were stained for CD11c using an anti-mouse anti-CD11c 185 
antibody (green, represented by white arrow. Figure 1A) as a marker for DCs
27
 and the 186 
presence of platelets using an anti-mouse anti-CD41 antibody (red. Figures 1B-D). CD11c
+
 cells 187 
were found in close proximity to the airway wall of sham (Figure 1B) and allergen-sensitized 188 
mice on day 15, before allergen exposure (Figure 1C). CD11c
+
 cells in tissue sections from 189 
allergen-sensitized mice show evidence of positive CD41 staining (Figure 1C), furthermore, 190 
individual platelets could be distinguished surrounding CD11c
+ 
cells (Figure 1D).   No difference 191 
in the number of CD11c
+
 cells was apparent between sham-sensitized and allergen-sensitized 192 
mice before allergen exposure (0 hours) on day 15 around the airway walls (Figure 1E). 24 193 
hours after allergen exposure (on day 16), a significant increase in CD11c
+
 cell localization was 194 
observed localized to the airway wall of allergen-sensitized mice (p<0.05, Figure 1E). 195 
Interestingly, there was also a significant increase in the incidence of platelets co-localized to 196 
CD11c
+
 cells around the airway walls in allergen-sensitized mice when compared to sham -197 
sensitized mice before allergen exposure (0 hours) on day 15 (sham-sensitized vs OVA-198 
sensitized p<0.05 Figure 1F). This co-localization around the airway wall was further increased 199 
24hours post allergen exposure on day 16 (sham-sensitized vs OVA-sensitized p<0.01 Figure 200 
1F). Thus, the observation that platelets co-localized with tissue CD11c
+
 cells in response to 201 




allergen sensitization suggests that platelet activation (e.g. migration, intercellular 202 
communication) occurs and may therefore be relevant during allergen recognition by APCs.   203 
 204 
Induction of temporary thrombocytopenia at time of allergen sensitization. 205 
 206 
To evaluate whether platelets are involved in allergen sensitization, we developed a novel 207 
protocol to make mice temporarily thrombocytopenic during, but importantly restricted to, the 208 
distinct period of allergen sensitization, rather than during allergen exposure as has been 209 
previously reported.
3,10-12,24-26
 Platelet depletion using an anti-GP1bα antibody induced a 95% 210 
reduction of circulating platelets when administered 24hours before each i.p. administration of 211 
OVA (10µg/mouse on days 0 and 7). Platelet counts were measured on day -1, day 0 (30 212 
minutes prior to allergen sensitization), day 9, and day 14. (Figure 2A). Platelet counts had 213 
recovered by day 14, 24 hours before the start of exposure to aerosolized allergen on day 15 214 
(Figure 2A). Importantly, temporary platelet depletion did not affect circulating leukocyte 215 
counts (Figure 2A).   216 
Platelet expression of FcεRI is increased during allergen sensitization, but is suppressed in the 217 
recovered platelet population when temporary thrombocytopaenia occurs during the period of 218 
allergen sensitization. 219 
 220 
Histological analysis revealed the co-localization of CD11c
+
 cells and platelets in lung tissue in 221 
allergen-sensitized mice before allergen exposure and our previous data revealed that the 222 
accumulation of platelets into the lung after sensitization was dependent on platelet FcεRI.
16
  223 
Furthermore, we have previously reported that the expression of FcεRI on platelets is increased 224 
in mice sensitized to allergen compared to sham-sensitized mice.
16
 We therefore examined the 225 
effect of platelet depletion at the time of sensitization on the expression of platelet FcεRI. Using 226 




a gating strategy to identify CD41+ platelet events by flow cytometry (Figure 2B) we identified 227 
FcɛRI on the surface of these cells (Figure 2C-E). On day 15, a significant increase in the 228 
proportion of platelets expressing FcεRI was observed in allergen-sensitized mice compared to 229 
sham-sensitized mice in the absence of allergen exposure (p<0.01, Figure 2F). This distinct 230 
population of platelets expressing FcεRI was significantly suppressed in allergen-sensitized mice 231 
depleted of platelets during the sensitization period compared to allergen-sensitized mice 232 
administered control IgG antibody (p<0.01 Figure 2F). Thus, given that only a distinct 233 
population of platelets express FcεRI, and murine platelet lifespan is 3-4 days, the process of 234 
sensitization to allergen continues to directly affect the manifestation of this platelet 235 
population, or bone marrow megakaryocytes sometime after the platelet population 236 
temporally associated with the administration of allergen would have been consumed. These 237 
data suggest that the sensitization process towards allergen directly affects the phenotype of 238 
circulating platelets. 239 
 240 
Temporary thrombocytopenia at time of allergen sensitization inhibits pulmonary leukocyte 241 
recruitment in response to subsequent allergen exposure. 242 
 243 
On days 15, 16, and 17, mice were exposed to aerosolized allergen (OVA). 24 hours post final 244 
allergen exposure (day 18), BALs were performed to enumerate pulmonary leukocyte 245 
recruitment. Allergen exposure induced significant pulmonary recruitment of inflammatory 246 
cells in allergen-sensitized mice compared to sham-sensitized mice (Eosinophils p<0.001 Figure 247 
3A; macrophages p<0.05 Figure 3B; neutrophils p<0.05 Figure 3C; and lymphocytes p<0.01 248 
Figure 3D).  The presence of thrombocytopaenia at the time of allergen sensitization in mice 249 




suppressed leukocyte recruitment compared to allergen-sensitized mice administered with the 250 
non-depleting control IgG antibody (Eosinophils p<0.01 Figure 3A; macrophages p<0.05 Figure 251 
3B). Lymphocyte recruitment was also suppressed, but not to a significant degree (Figure 3D), 252 
whilst neutrophil recruitment was not altered in platelet depleted animals (Figure 3C).  253 
 254 
 255 
Temporary thrombocytopenia at the time of allergen sensitization, suppresses IgE and IL-4 256 
production. 257 
 258 
We next investigated whether platelet depletion during the phase of allergen sensitization 259 
might affect the immune phenotype of the mice.  IL-4, IL-5 and IFN-γ levels in lavage fluid, and 260 
IgE in serum, were measured from samples taken on day 18, 24hours after the last day of 261 
allergen exposure on day 17. Significantly increased levels of IgE, IL-4, and IL-5, but not IFN-γ, 262 
were observed in allergen-sensitized mice compared to sham sensitized mice (IgE: p<0.05 263 
Figure 4A; IL-4 p<0.05 Figure 4B; IL-5 p<0.05 Figure 4C). Temporary thrombocytopaenia during 264 
the period of allergen sensitization resulted in a suppression of IgE production (p<0.05 Figure 265 
4A) and IL-4 production (p<0.05 Figure 4B). Whilst IL-5 production (Figure 4C) and IFN-γ were 266 
not affected (Figure 4D); these data nonetheless suggest that platelets directly affect the Th2 267 
sensitization process during this period. 268 
 269 
Temporary thrombocytopaenia during the sensitization process inhibits pulmonary CD11c+ cell 270 
recruitment.  271 
We have previously reported that in non-inflamed tissue, there are a small number of platelets 272 
that reside in lung tissue, and 90% of these are attached to mononuclear cells.
16
 Indeed, there 273 
is a 29.7% increase in these events in OVA-sensitized mice compared to sham-sensitized mice 274 




as measured by immunohistochemistry of lung tissue sections for CD41 positive events (Sham: 275 
84.1±20.6 platelets/mm
2
 vs OVA: 109.1±31.9 platelets/mm
2
 from ref 
16
). Furthermore, this 276 
increased accumulation of platelets extravascularly and their association with mononuclear 277 
cells was suppressed in mice deficient in functional FcɛRI, suggesting that platelet localization to 278 
lung-resident mononuclear cells in response to allergen sensitization was dependent on platelet 279 
activation via FcɛRI.
16 
 Given that platelet FcɛRI expression is significantly decreased in animals 280 
made temporarily thrombocytopaenic at the time of allergen sensitization (Figure 2F), we 281 
assessed whether the increase in CD11c
+
 cell number in the lungs after allergen exposure 282 
(Figure 1F) was platelet dependent. Lungs were taken from either sham-sensitized or allergen–283 
sensitized mice at either 0 (day 15) or 24 hours (day 16) after allergen exposure, and processed 284 
into a single cell suspension to allow quantitative flow cytometry of CD11c
+
 events with the use 285 
of a fixed number of fluorescent beads to assist with accurate enumeration (Figure 5A). In 286 
accordance with immunohistochemistry of mouse lungs, a significant increase in the number of 287 
CD11c
+
 cells was observed 24 hours post allergen exposure on day 16 in allergen-sensitized 288 
mice compared to sham-sensitized mice (p<0.001, Figure 5C), and was a result of secondary 289 
allergen exposure, rather than the sensitization process, since no increase in CD11c
+
 cells was 290 
observed before allergen exposure (0 hours) on day 15 (Figure 5B). This accumulation was 291 
reduced in allergen-sensitized mice rendered temporarily thrombocytopaenic during the period 292 
of allergen sensitization (p<0.05, Figure 5C), suggesting that allergen-exposed platelets are 293 
necessary for pulmonary CD11c
+ 
cell recruitment.  294 
 295 






We have shown for the first time that platelets are causal in the initial processing of allergen in 298 
vivo.  The temporary depletion of platelets during the initial sensitization period suppressed 299 
inflammatory cell recruitment upon subsequent allergen exposure (aerosol allergen challenge, 300 
Figure 3) and this correlated with an inhibition of IL-4 synthesis and IgE production (Figure 4). 301 
We have previously reported that allergen can induce platelet motility and migration into lungs 302 
after allergen exposure,
16
 whilst others have also reported activation of platelets via IgE-303 
dependent mechanisms.
18
 As we report here, one consequence of platelet accumulation into 304 
tissue in response to allergen is their co-localisation with CD11c
+
 cells, a phenomenon that 305 
occurs before subsequent allergen exposure (Figure 1). Given the reduction in the Th2 306 
response, we conclude that the actions of platelets during allergen-sensitization are probably 307 
delivered via an IgE-dependent FcεRI process to interact with lung APCs, for example CD11c
+
 308 
DCs to process allergen signalling with T-cells in bronchial lymph nodes, although the data in 309 
this manuscript are restricted to CD11c
+ 
cells, rather than specifically DCs that express the 310 
CD11c antigen. We note that in contrast to other studies,
24
 we do not observe effects of 311 
platelet depletion on IgE and Th2 cytokine production after allergen exposure, either acutely (3 312 
days of allergen exposure) or chronically (8 weeks of allergen exposure), and the effects of 313 








The phenomenon that allergen-exposed platelets are necessary for pulmonary CD11c
+ 
cell 316 
recruitment after secondary allergen exposure was unlikely to be due to an inability of the 317 
restored platelet population to efficiently recruit CD11c
+
 cells from the circulation, as our 318 
previous studies have revealed platelets from non allergen-sensitized mice retain their ability to 319 
recruit leukocytes.
3
   Furthermore, neutrophil recruitment to the lungs was not influenced by 320 
platelet depletion at the time of allergen sensitization, even though it is well understood that 321 





It remains to be understood why professional APCs such as DCs might require platelet 324 
interactions for a more efficient processing of allergen in vivo. DCs also express FcεRI in 325 
different conformations with cross-linked IgE, yet it has been reported that IgE-mediated 326 
activation of DCs in allergic Th-2 type inflammation might be immune-regulatory rather than 327 
pro-inflammatory.
27,28
 Clearly, IgE/FcεRI-mediated antigen presentation by DCs is considered to 328 
be a critical event in the priming of Th2-type cells,
29
 but recent evidence suggests that this 329 
response is dependent on low antigen concentrations, rather than receptor signalling per se.
30
 T 330 
cell activities induced after IgE/FcεRI dependent processes by DCs have been reported not to 331 
develop as efficiently into Th2-type effector cells than those generated via an IgE/FcεRI 332 
independent process.
31
 How DCs process antigen and elicit a Th-2 type response is complex, 333 
and might therefore involve other cell types, including platelets that have been implicated in 334 
the innate response and express FcεRI, CD23, and other Immunoglobulin receptors, as well as 335 
toll-like receptors (TLRs).
2
 Indeed, it has been reported that platelet communication with APCs 336 
is regulated by CD40/CD40L interactions, and this might be an important component of DC 337 




communication with T cells in the draining lymph nodes after platelet activation by allergen.
32,33 
338 
Currently, our understanding as to why APCs might require platelets to effect an immune 339 
response is incomplete, but perhaps platelet activation by allergen or pathogens via IgE-340 
dependent processes is a more direct, innate response, with less regulation and control. Two 341 
recent studies report the ability of platelets to modulate the immune response in mouse 342 
models of eosinophilic and allergic airway inflammation.
34,35
 The transfer of human platelets 343 
restored papain-induced airway eosinophilia on an IL-33 deficient background in mice, 344 
supporting a hypothesis that platelets are important in the IL-33 dependent provocation of Th2 345 
immune cells.
34
 Furthermore, the platelet derived Wnt antagonist Dickkopf-1 was reported to 346 
be important for Th2 cell cytokine production in a house dust mite (HDM) model of asthma.
35 
347 
The pathways by which platelets might affect sensitization to allergens in patients with asthma 348 
has not yet been described, but it is of interest that platelets from patients allergic to 349 
Dermatophagoides pteronyssinus have been shown to be activated directly by the specific 350 
allergen, and not activated by other known allergens to which the allergic blood donor was not 351 
sensitized to.
16,18 
Thus, clinical data is suggestive of a interaction between platelets and the 352 
sensitization process. 353 
 354 
It is not understood how induced expression of FcεRI occurs on circulating platelets (Figure 2). 355 
The percentage of platelets that express these receptors remains a small subset of the whole 356 
platelet population, which might suggest that megakaryocytes residing in the bone marrow are 357 
capable of differentiation to ultimately determine the phenotype of subsets of platelets. It is 358 




interesting to note however, that this increase in platelet FcεRI expression is suppressed in mice 359 
subjected to the temporary thrombocytopaenia at the time of allergen sensitization (Figure 2). 360 
The lifespan of murine platelets is between 3-4 days, yet the recording was taken when the 361 
platelet population had fully recovered, suggesting that there is an establishment of immune 362 
memory in a subset of megakaryocytes to continue producing a population of platelets with 363 
increased expression of FcεRI.  364 
 365 
To conclude, the initial processing of antigen in naive animals requires the involvement of 366 
platelets, and leads to an increased production of allergen responsive platelets perhaps 367 
transmitted from megakaryocytes during thrombopoesis, and supports earlier clinical data 368 
reporting the ability of platelets to become activated by specific allergens to which individual 369 
patients with allergy become sensitized to.
16,18,36
 These platelets respond by recruiting to 370 
organs that are exposed to the external environment and migrate to prime resident APCs for an 371 


















Figure Legends  386 
Figure 1. Association of platelets with CD11c
+
 cells in lungs of allergen-sensitized mice. Lungs 387 
from either sham-sensitized or allergen sensitized (OVA) mice were collected at 0, 24, or 48 388 
hours after exposure to aerosolised OVA from day 15. Lung sections were stained for the 389 
presence of CD41
+
 (platelets, red fluorescence) and CD11c+ cells (green fluorescence): 390 
Representation of CD11c+ cell (white arrow) (A); platelets and CD11c
+
 cells localised to airways 391 
in sham sensitized (B) and allergen-sensitized mice (C). Arrows indicate presence of CD11c
+
 392 
cells. A ‘zoomed’ image (using Microsoft Office) represented in the dotted oblong (C) shows 393 
individual platelets (red) attached to the CD11c+ cell (D).  Images photographed using a x40 394 
objective under a Zeiss Axiovert microscope. Images A-D were enhanced to improve 395 
brightness/contrast using Microsoft Powerpoint. The presence of CD11c+ cells was quantified 396 
around airway walls (E). The percentage of CD11c+ cells co-localized with CD41+ platelets was 397 
determined within the airway walls (F). n=4 per group. **P< 0.01, *P< 0.05 compared to sham 398 
control group.  399 
 400 
Figure 2. Induction of temporary thrombocytopaenia during the period of allergen 401 
sensitization and effects on platelet FcERI expression. Mice were administered either a control 402 
IgG antibody, or platelet-depleting anti-GPIbα antibody on days -1 and 6 of the sensitization 403 
procedure to deplete circulating platelets within the time frame of allergen sensitization (OVA) 404 
on days 0 and 7 (A). Tail vein bleeds were conducted on days -1, 0, 9, and 14 to enumerate 405 




circulating platelet and leukocyte numbers (A). Representative histograms show CD41+ 406 
platelets from lysed whole blood (B), FcɛRI expression in sham-sensitized (C), OVA-sensitized + 407 
IgG (D), and OVA-sensitized + anti-GPIbα mice (E). Expression recorded as % of cells expressing 408 
antigen on day 15 in the absence of secondary allergen exposure (F). n=4-5 per group. Data: 409 
means ±SEM. **P< 0.01 versus sham-sensitised control group, ##P<0.01 versus OVA-sensitised 410 
IgG group. 411 
 412 
Figure 3. Effects of temporary thrombocytopaenia during the period of allergen sensitization 413 
on the inflammatory response after subsequent allergen exposure. Mice were administered 414 
either a control IgG antibody, or platelet-depleting anti-GPIbα antibody on days -1 and 6 of the 415 
sensitization procedure to deplete circulating platelets within the time frame of allergen 416 
sensitization (OVA) on days 0 and 7. On days 15, 16, and 17, mice were subsequently exposed 417 
to aerosolized allergen (OVA) for 30 mins/day before BAL was performed on day 18 and 418 
enumerated for eosinophils (B), macrophages (C), neutrophils (D), and lymphocytes (E). n=8-12 419 
per group. Data: means± SEM.  *P< 0.05, **P< 0.01, ***P< 0.001 versus sham-sensitised control 420 
group.  #P< 0.05, ##P< 0.01, versus OVA-sensitised group (OVA+ IgG). 421 
 422 
Figure 4. Effects of temporary thrombocytopaenia during the period of allergen sensitization 423 
on the cytokine expression and IgE titre after subsequent allergen exposure. Mice were 424 
administered either a control IgG antibody, or platelet-depleting anti-GPIbα antibody on days -1 425 
and 6 of the sensitization procedure to deplete circulating platelets within the time frame of 426 




allergen sensitization (OVA) on days 0 and 7. On days 15, 16, and 17, mice were subsequently 427 
exposed to aerosolized allergen (OVA) for 30 mins/day before BAL and blood was harvested on 428 
day 18 for plasma IgE analysis (A), and BAL enumerated for IL-4 (B), IL-5 (C), and IFNγ (D) titres.  429 
n=6-8 per group. Data: means± SEM.  *P< 0.05 versus sham-sensitised control group.  #P< 0.05 430 
versus OVA-sensitised group (OVA+ IgG). 431 
 432 
 433 
Figure 5. Effect of platelets and allergen on DC recruitment. Allergen-sensitized mice had 434 
previously been administered either control IgG or platelet-depleting anti-GPIbα antibody 435 
during the allergen sensitization period, and lungs were harvested at 0 (day 15) and 24 hours 436 
after (day 16) exposure to aerosolized allergen (OVA) for histology or flow cytometry. Lungs 437 
were processed into a single cell suspension and CD11c+ cells were quantified via flow 438 
cytometry using fluorospheres to obtain an accurate count (A) at 0 hours (B), 24 hours (C) post 439 
allergen challenge. n=3-9. Data: means± SEM.  ***P< 0.001 versus sham-sensitized group; and 440 
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A.Blood microsampling 
For blood microsampling to enumerate circulating platelet and leukocyte numbers, mice 
were placed in a heated chamber (37 °C) for 10 minutes before a 1-2 mm cut was made with 
a scalpel blade across the lateral tail vein. Using a micropipette, 2 µl of blood was diluted 
1:100 into stromatol solution for platelet counts, a further 2 µl diluted 1:50 in Turk’s 
solution for leukocyte counts (both using a Neubauer improved haemocytometer). Manual 
counts were made using a Zeiss Axiovert microscope.  
 
B.Immunohistochemistry of lungs. 
At 0h, 24h, and 48h, post one day of allergen challenge on day 15, lungs were recovered 
from terminally anaesthetized mice.  Lungs were inflated with a tracheal cannula with 4% 
PFA and then immersed to fix in 4% PFA for 1 hour. The lungs were then incubated in 10% 
sucrose solution (in PBS) overnight at 4˚C. The sucrose solution was then replaced with 25% 
OCT (in PBS) for 1 hour, and then with 100% OCT for 1 hour. Lungs were then stored at -
80°C, after which they were sectioned (6μm) with a Cryostat and placed on poly-L-lysine 
coated microscope slides.  Tissue sections were stained with primary antibodies to detect 
CD11c+ cells (hamster anti-mouse CD11c Integrin αx chain, HL3, BD Biosciences) and 
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platelets (Goat polyclonal IgG Integrin αIIb. k-18, Santa Cruz Biotech), for 2 hours.  Slides 
containing lung sections were then washed and incubated with secondary fluorescent 
antibodies: 1. Donkey anti-goat IgG-Cy3 for 1 hour, before PBS wash followed by 2. Goat-
anti Armenian hamster IgG-FITC for 1 hour. Finally, slides were cover slipped using a photo 
bleaching protecting mountant and stored in the dark at 4°C until required for microscopic 
analysis. 
 
C. Microscopic analysis and Lung morphometry 
 
Lung section slides were analysed under a fluorescent microscope (Zeiss Axioskop) using a 
x100 objective, where CD11c+ cell localisation was measured around airway walls to a depth 
of 50 μm beneath the sub-epithelial basement membrane, in a five field area. CD11c+ cells 
were investigated for platelet co-localisation (CD41+ events) and the extent of those with 
positive results quantified per airway
 
using an image analysis programme (Scion Image; 
National Institutes of Health, Bethesda, MD).  
 
D.Flow cytometric analysis of CD11c+ cells and platelets  
All experiments were analysed on a flow cytometer (FC500 series Beckman Coulter) as 
previously described.
10,16 
Single cell suspensions isolated from lung digestion at 0 and 24 
hours after allergen challenge on day 15 were incubated with the DC marker, anti-CD11c-
fluorescein mAb, in a saturating concentration for 30 minutes at room temperature away 
from direct light.  For quantification of CD11c+ cells, samples were also treated with 
Beckman coulter Flow Count
TM
 fluorosphere beads (Beckman Coulter). Specific gating 
parameters were set up to calibrate for the assayed concentration of the fluorospheres to 
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allow absolute quantification of anti-CD11c-fluorescein positive events. For analysis of 
Platelet FcεRI expression, citrated blood was obtained via cardiac puncture on other groups 
of mice on day 15 in the absence allergen challenge (0 hours). Blood was incubated with 
platelet specific anti-CD41-phycoerythrin mAb and anti-FcεRI-fluorescein mAb in saturating 
concentrations for 30 minutes at room temperature and platelets were gated on size and 
FcεRI positive events were then measured on CD41 positive cells.  
 
E. Quantification of IgE, IL-4, IL-5, and IFN-γ 
Bronchoalveolar lavage samples taken at day 18 were centrifuged at 300 G for 5 minutes 
and supernatants harvested for quantification of IL-4, IL-5, and IFN-γ using specific ELISAs as 
per the manufacturer’s instructions (Duoset, R&D systems). Total IgE was measured in 
plasma samples prepared from citrated blood harvested via cardiac puncture at day 18. A 
murine specific IgE ELISA was used as per the manufacturer’s instructions (BD Pharmingen. 
Primary capture antibody: rat anti-mouse IgE clone R35-72). 
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Background: Platelet activation occurs in patients with allergic inflammation, and platelets can 36 
be activated directly by allergen via an IgE-dependent process. Platelets have been shown to 37 
activate antigen-presenting cells (APCs) such as CD11c
+
 dendritic cells (DCs) in vitro. Whilst 38 
CD11c
+
 DCs are requisite for allergen sensitization, the role of platelets in this process is 39 
unknown.  40 
Objectives: We investigated whether platelets were necessary for allergen sensitization. 41 
Methods: Balb/c mice sensitised to ovalbumin (OVA), were exposed to subsequent aerosolized 42 
allergen (OVA challenge). We analysed lung CD11c
+
 cell activation, co-localization with 43 
platelets, and some other indices of inflammation. The role of platelets at the time of allergen 44 
sensitization was assessed through platelet depletion experiments restricted to the period of 45 
sensitization.  46 
Results: Platelets co-localized with airway CD11c
+
 cells, and this association increased after 47 
allergen sensitization, and after subsequent allergen exposure. Temporary platelet depletion 48 
(>95%) at the time of allergen sensitization led to a suppression of IgE and IL-4 synthesis, and a 49 
decrease in the pulmonary recruitment of eosinophils, macrophages, and lymphocytes after 50 
subsequent allergen exposure. Furthermore, in mice previously depleted of platelets at the 51 
time of sensitization, the recovered platelet population were shown to have reduced 52 
expression of FcɛRI. Pulmonary CD11c
+
 cell recruitment was suppressed in these mice after 53 
allergen challenge, suggesting the migration of CD11c
+ 
cells in vivo may be dependent on direct 54 
platelet recognition of allergen. 55 




Conclusion: Platelets are necessary for efficient host sensitization to allergen. This propagates 56 
the subsequent inflammatory response during secondary allergen exposure, and increases 57 
platelet association with airway CD11c
+
 cells. 58 
 59 
Keywords: Platelets, allergen sensitization, FcεRI, IgE, IL-4, CD11c, dendritic cells, leukocyte 60 
recruitment, asthma 61 
 62 
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Platelet activation in allergic diseases such as asthma, has been reported extensively over the 79 
last 30 years, with evidence of changes in platelet volume, presence of platelet micro-particles, 80 
release of platelet-specific inflammatory mediators, and an increased incidence of circulating 81 
platelet-leukocyte (including eosinophil) complexes, both in patients undergoing spontaneous 82 
asthma attacks or after allergen challenge.
1-4
 Furthermore, platelet activation correlates 83 
strongly to changes in lung function.
4-9
 Various in vivo studies confirm that the activation of 84 
platelets during allergy and asthma plays a central role in  the inflammatory response.
3,10-13
 Of 85 
significance, pulmonary platelet recruitment and accumulation occurs in the lungs, initially via 86 
an IgE-dependent process whereby platelets migrate and enter the extravascular space.
7,14-17
 87 
The significance and temporal nature of allergen-induced activation of platelets, via FcεRI, has 88 
not been established, yet of pertinence to allergy, platelets from patients allergic to 89 
Dermatophagoides pteronyssinus have been shown to be activated directly by the specific 90 
allergen, or by synthetic peptides derived from the allergen, through an IgE dependent 91 
process.
16,18
 Combined, these studies argue for a causal role of platelet activation in asthma and 92 
allergy, and that such activation is not as a consequence of the inflammatory milieu per se. 93 
Furthermore, it has been shown that platelet-derived 5-HT is also important for dendritic cell 94 
(DC) activation during allergic airways inflammation, further supporting a role for platelets, and 95 
suggesting that the activation and migration of platelets induced by allergen might be of 96 
significance or causal to the sensitization process.
19
  97 
Myeloid DCs (mDCs) are thought to be involved very early in the development of asthma by 98 
inducing sensitization to inhaled antigen, and increasingly, mDCs are viewed as essential pro-99 




inflammatory cells that induce effector cytokine production in primed Th2 cells during airway 100 
inflammation.
20-23
 It is therefore of interest that platelet CD40L has recently been reported to 101 
be involved in the promotion of allergic airways inflammation by polarizing Th2 responses after 102 
allergen exposure.
24
 We have previously demonstrated a presence of platelets extra-vascularly 103 
in the lungs of mice before subsequent allergen exposure in allergen-sensitized mice, but the 104 
vast majority of these platelets were attached to a resident undefined mononuclear cell 105 
population, and the relevance of this occurrence has yet to be established.
16
 We hypothesized 106 
that these platelets are a distinct population that had migrated to the lungs as a result of 107 
exposure to allergen (ip injection of ovalbumin, OVA), and that a population of platelets might 108 
therefore be involved in initial sensitization to allergen. Temporally, the occurrence was clearly 109 
unrelated to subsequent aerosolized exposures to allergen (OVA), which drives platelet 110 
migration into the lungs along with recruited leukocytes.
16
 We report here that CD11c
+
 cells (as 111 
a marker for DCs) are decorated with platelets during allergen sensitization, and investigate the 112 
importance of these platelets during the process of allergen sensitization and their interactions 113 
with CD11c
+
 cells, before and during subsequent exposure to aerosolized allergen. These 114 
studies provide a possible role for the specific activation of platelets by allergen from patients 115 










Materials and Methods  122 
Readers are directed to the online supplementary material document for methodology related 123 
to: Blood microsampling, Immunohistochemistry of lungs, Microscopic analysis and lung 124 
morphometry, Flow cytometric analysis of CD11c+ cells and platelets, and: Quantification of 125 
IgE, IL-4, IL-5, and IFN-γ. 126 
 127 
1. Sensitisation of mice to ovalbumin and bronchoalveolar lavage (BAL). 128 
To understand the importance of platelets during allergen sensitization, and subsequent effects 129 
on the inflammatory response after secondary allergen exposure via an aerosol challenge, a 130 
murine model of allergic sensitization and lung inflammation was used where the sensitization 131 
process can be delineated and confined by a defined route of administration (intraperitoneal 132 
route) compared to the more complex situation arising from continual exposure to allergen via 133 
the airways. All studies were carried out under the Animals (Scientific Procedures) Act of 1986, 134 
and amendments 2012 (United Kingdom) with local ethical approval from King’s College, 135 
London. Studies and reporting have been undertaken under the ARRIVE guidelines. Female 136 
Balb/c mice (20-25g; Harlan UK), housed under standard husbandry conditions of 12 hour 137 
light/dark cycle, 21-23⁰C, in groups of 4-6 animals per cage with access to pelleted chow diet 138 
and water ad libitum, were randomly assigned to different treatment groups. Mice were 139 
sensitised with chicken egg ovalbumin (OVA, grade V, Sigma-Aldrich; 10µg/0.4ml, absorbed in a 140 
saturated solution of an adjuvant: aluminium hydroxide, 0.1M, Sanofi Winthrop), or received 141 




adjuvant only (sham-sensitized mice), intraperitoneally (i.p.) on days 0 and 7. On days 15, 16, 142 
and 17, mice were subsequently nebulised with OVA (10mg/ml) for 30 minutes, 24 hours post 143 
final allergen challenge (day 18).  BAL fluid was processed for total and differential cell counts, 144 
and the enumeration of cytokines, whilst blood was processed for measurement of total IgE 145 
content as previously described.
10,25
 Some groups of mice were sacrificed 0, 24, and 48h after 146 
one day of allergen exposure on day 15, and lungs taken for histological analysis. Groups of 147 
mice were also sacrificed on day 15 in the absence of allergen exposure for measurement of 148 
platelet FcɛRI expression from circulating blood, and (day 15: absence of allergen challenge, day 149 
16, 24 hours post day 15 allergen challenge) for enumeration of CD11c+ cells in lung 150 
homogenates.   151 
 152 
2. Platelet depletion  153 
In order to produce profound, yet temporary, platelet depletion for the selective period of 154 
allergen sensitization, groups of mice were administered intra-muscularly (i.m. 50µL into a 155 
hindlimb) with 25µg/mouse anti-platelet antibody (anti GP1bα, Emfret Technologies) or control 156 
IgG (monoclonal 2A3 anti-trinitrophenol, BioXCell) 24h prior to allergen sensitizations on days -157 
1 and 6. Previous studies in our laboratory have demonstrated that mice receiving this 158 
antiplatelet antibody do not display pulmonary oedema, haemorrhage, or weight loss beyond 159 
10% body weight.  160 
 161 
3. Statistical Analysis 162 




The experimenters were blinded to the identity of experimental groups for the manual 163 
quantification of tissue samples/ cells. Data from allergic animal studies are presented as mean 164 
± standard error of the mean (SEM), and analysed by one-way ANOVA, followed by Bonferroni’s 165 





















 cell and platelet co-localisation occurs in the airways during sensitization to allergen. 181 
 182 
Platelets, in low numbers, have previously been observed adjacent to mononuclear cells in 183 
lungs of mice before allergen exposure.
16
 To identify these cells, and to quantify the extent of 184 
platelet decoration, lung sections were stained for CD11c using an anti-mouse anti-CD11c 185 
antibody (green, represented by white arrow. Figure 1A) as a marker for DCs
27
 and the 186 
presence of platelets using an anti-mouse anti-CD41 antibody (red. Figures 1B-D). CD11c
+
 cells 187 
were found in close proximity to the airway wall of sham (Figure 1B) and allergen-sensitized 188 
mice on day 15, before allergen exposure (Figure 1C). CD11c
+
 cells in tissue sections from 189 
allergen-sensitized mice show evidence of positive CD41 staining (Figure 1C), furthermore, 190 
individual platelets could be distinguished surrounding CD11c
+ 
cells (Figure 1D).   No difference 191 
in the number of CD11c
+
 cells was apparent between sham-sensitized and allergen-sensitized 192 
mice before allergen exposure (0 hours) on day 15 around the airway walls (Figure 1E). 24 193 
hours after allergen exposure (on day 16), a significant increase in CD11c
+
 cell localization was 194 
observed localized to the airway wall of allergen-sensitized mice (p<0.05, Figure 1E). 195 
Interestingly, there was also a significant increase in the incidence of platelets co-localized to 196 
CD11c
+
 cells around the airway walls in allergen-sensitized mice when compared to sham -197 
sensitized mice before allergen exposure (0 hours) on day 15 (sham-sensitized vs OVA-198 
sensitized p<0.05 Figure 1F). This co-localization around the airway wall was further increased 199 
24hours post allergen exposure on day 16 (sham-sensitized vs OVA-sensitized p<0.01 Figure 200 
1F). Thus, the observation that platelets co-localized with tissue CD11c
+
 cells in response to 201 




allergen sensitization suggests that platelet activation (e.g. migration, intercellular 202 
communication) occurs and may therefore be relevant during allergen recognition by APCs.   203 
 204 
Induction of temporary thrombocytopenia at time of allergen sensitization. 205 
 206 
To evaluate whether platelets are involved in allergen sensitization, we developed a novel 207 
protocol to make mice temporarily thrombocytopenic during, but importantly restricted to, the 208 
distinct period of allergen sensitization, rather than during allergen exposure as has been 209 
previously reported.
3,10-12,24-26
 Platelet depletion using an anti-GP1bα antibody induced a 95% 210 
reduction of circulating platelets when administered 24hours before each i.p. administration of 211 
OVA (10µg/mouse on days 0 and 7). Platelet counts were measured on day -1, day 0 (30 212 
minutes prior to allergen sensitization), day 9, and day 14. (Figure 2A). Platelet counts had 213 
recovered by day 14, 24 hours before the start of exposure to aerosolized allergen on day 15 214 
(Figure 2A). Importantly, temporary platelet depletion did not affect circulating leukocyte 215 
counts (Figure 2A).   216 
Platelet expression of FcεRI is increased during allergen sensitization, but is suppressed in the 217 
recovered platelet population when temporary thrombocytopaenia occurs during the period of 218 
allergen sensitization. 219 
 220 
Histological analysis revealed the co-localization of CD11c
+
 cells and platelets in lung tissue in 221 
allergen-sensitized mice before allergen exposure and our previous data revealed that the 222 
accumulation of platelets into the lung after sensitization was dependent on platelet FcεRI.
16
  223 
Furthermore, we have previously reported that the expression of FcεRI on platelets is increased 224 
in mice sensitized to allergen compared to sham-sensitized mice.
16
 We therefore examined the 225 
effect of platelet depletion at the time of sensitization on the expression of platelet FcεRI. Using 226 




a gating strategy to identify CD41+ platelet events by flow cytometry (Figure 2B) we identified 227 
FcɛRI on the surface of these cells (Figure 2C-E). On day 15, a significant increase in the 228 
proportion of platelets expressing FcεRI was observed in allergen-sensitized mice compared to 229 
sham-sensitized mice in the absence of allergen exposure (p<0.01, Figure 2F). This distinct 230 
population of platelets expressing FcεRI was significantly suppressed in allergen-sensitized mice 231 
depleted of platelets during the sensitization period compared to allergen-sensitized mice 232 
administered control IgG antibody (p<0.01 Figure 2F). Thus, given that only a distinct 233 
population of platelets express FcεRI, and murine platelet lifespan is 3-4 days, the process of 234 
sensitization to allergen continues to directly affect the manifestation of this platelet 235 
population, or bone marrow megakaryocytes sometime after the platelet population 236 
temporally associated with the administration of allergen would have been consumed. These 237 
data suggest that the sensitization process towards allergen directly affects the phenotype of 238 
circulating platelets. 239 
 240 
Temporary thrombocytopenia at time of allergen sensitization inhibits pulmonary leukocyte 241 
recruitment in response to subsequent allergen exposure. 242 
 243 
On days 15, 16, and 17, mice were exposed to aerosolized allergen (OVA). 24 hours post final 244 
allergen exposure (day 18), BALs were performed to enumerate pulmonary leukocyte 245 
recruitment. Allergen exposure induced significant pulmonary recruitment of inflammatory 246 
cells in allergen-sensitized mice compared to sham-sensitized mice (Eosinophils p<0.001 Figure 247 
3A; macrophages p<0.05 Figure 3B; neutrophils p<0.05 Figure 3C; and lymphocytes p<0.01 248 
Figure 3D).  The presence of thrombocytopaenia at the time of allergen sensitization in mice 249 




suppressed leukocyte recruitment compared to allergen-sensitized mice administered with the 250 
non-depleting control IgG antibody (Eosinophils p<0.01 Figure 3A; macrophages p<0.05 Figure 251 
3B). Lymphocyte recruitment was also suppressed, but not to a significant degree (Figure 3D), 252 
whilst neutrophil recruitment was not altered in platelet depleted animals (Figure 3C).  253 
 254 
 255 
Temporary thrombocytopenia at the time of allergen sensitization, suppresses IgE and IL-4 256 
production. 257 
 258 
We next investigated whether platelet depletion during the phase of allergen sensitization 259 
might affect the immune phenotype of the mice.  IL-4, IL-5 and IFN-γ levels in lavage fluid, and 260 
IgE in serum, were measured from samples taken on day 18, 24hours after the last day of 261 
allergen exposure on day 17. Significantly increased levels of IgE, IL-4, and IL-5, but not IFN-γ, 262 
were observed in allergen-sensitized mice compared to sham sensitized mice (IgE: p<0.05 263 
Figure 4A; IL-4 p<0.05 Figure 4B; IL-5 p<0.05 Figure 4C). Temporary thrombocytopaenia during 264 
the period of allergen sensitization resulted in a suppression of IgE production (p<0.05 Figure 265 
4A) and IL-4 production (p<0.05 Figure 4B). Whilst IL-5 production (Figure 4C) and IFN-γ were 266 
not affected (Figure 4D); these data nonetheless suggest that platelets directly affect the Th2 267 
sensitization process during this period. 268 
 269 
Temporary thrombocytopaenia during the sensitization process inhibits pulmonary CD11c+ cell 270 
recruitment.  271 
We have previously reported that in non-inflamed tissue, there are a small number of platelets 272 
that reside in lung tissue, and 90% of these are attached to mononuclear cells.
16
 Indeed, there 273 
is a 29.7% increase in these events in OVA-sensitized mice compared to sham-sensitized mice 274 




as measured by immunohistochemistry of lung tissue sections for CD41 positive events (Sham: 275 
84.1±20.6 platelets/mm
2
 vs OVA: 109.1±31.9 platelets/mm
2
 from ref 
16
). Furthermore, this 276 
increased accumulation of platelets extravascularly and their association with mononuclear 277 
cells was suppressed in mice deficient in functional FcɛRI, suggesting that platelet localization to 278 
lung-resident mononuclear cells in response to allergen sensitization was dependent on platelet 279 
activation via FcɛRI.
16 
 Given that platelet FcɛRI expression is significantly decreased in animals 280 
made temporarily thrombocytopaenic at the time of allergen sensitization (Figure 2F), we 281 
assessed whether the increase in CD11c
+
 cell number in the lungs after allergen exposure 282 
(Figure 1F) was platelet dependent. Lungs were taken from either sham-sensitized or allergen–283 
sensitized mice at either 0 (day 15) or 24 hours (day 16) after allergen exposure, and processed 284 
into a single cell suspension to allow quantitative flow cytometry of CD11c
+
 events with the use 285 
of a fixed number of fluorescent beads to assist with accurate enumeration (Figure 5A). In 286 
accordance with immunohistochemistry of mouse lungs, a significant increase in the number of 287 
CD11c
+
 cells was observed 24 hours post allergen exposure on day 16 in allergen-sensitized 288 
mice compared to sham-sensitized mice (p<0.001, Figure 5C), and was a result of secondary 289 
allergen exposure, rather than the sensitization process, since no increase in CD11c
+
 cells was 290 
observed before allergen exposure (0 hours) on day 15 (Figure 5B). This accumulation was 291 
reduced in allergen-sensitized mice rendered temporarily thrombocytopaenic during the period 292 
of allergen sensitization (p<0.05, Figure 5C), suggesting that allergen-exposed platelets are 293 
necessary for pulmonary CD11c
+ 
cell recruitment.  294 
 295 






We have shown for the first time that platelets are causal in the initial processing of allergen in 298 
vivo.  The temporary depletion of platelets during the initial sensitization period suppressed 299 
inflammatory cell recruitment upon subsequent allergen exposure (aerosol allergen challenge, 300 
Figure 3) and this correlated with an inhibition of IL-4 synthesis and IgE production (Figure 4). 301 
We have previously reported that allergen can induce platelet motility and migration into lungs 302 
after allergen exposure,
16
 whilst others have also reported activation of platelets via IgE-303 
dependent mechanisms.
18
 As we report here, one consequence of platelet accumulation into 304 
tissue in response to allergen is their co-localisation with CD11c
+
 cells, a phenomenon that 305 
occurs before subsequent allergen exposure (Figure 1). Given the reduction in the Th2 306 
response, we conclude that the actions of platelets during allergen-sensitization are probably 307 
delivered via an IgE-dependent FcεRI process to interact with lung APCs, for example CD11c
+
 308 
DCs to process allergen signalling with T-cells in bronchial lymph nodes, although the data in 309 
this manuscript are restricted to CD11c
+ 
cells, rather than specifically DCs that express the 310 
CD11c antigen. We note that in contrast to other studies,
24
 we do not observe effects of 311 
platelet depletion on IgE and Th2 cytokine production after allergen exposure, either acutely (3 312 
days of allergen exposure) or chronically (8 weeks of allergen exposure), and the effects of 313 








The phenomenon that allergen-exposed platelets are necessary for pulmonary CD11c
+ 
cell 316 
recruitment after secondary allergen exposure was unlikely to be due to an inability of the 317 
restored platelet population to efficiently recruit CD11c
+
 cells from the circulation, as our 318 
previous studies have revealed platelets from non allergen-sensitized mice retain their ability to 319 
recruit leukocytes.
3
   Furthermore, neutrophil recruitment to the lungs was not influenced by 320 
platelet depletion at the time of allergen sensitization, even though it is well understood that 321 





It remains to be understood why professional APCs such as DCs might require platelet 324 
interactions for a more efficient processing of allergen in vivo. DCs also express FcεRI in 325 
different conformations with cross-linked IgE, yet it has been reported that IgE-mediated 326 
activation of DCs in allergic Th-2 type inflammation might be immune-regulatory rather than 327 
pro-inflammatory.
27,28
 Clearly, IgE/FcεRI-mediated antigen presentation by DCs is considered to 328 
be a critical event in the priming of Th2-type cells,
29
 but recent evidence suggests that this 329 
response is dependent on low antigen concentrations, rather than receptor signalling per se.
30
 T 330 
cell activities induced after IgE/FcεRI dependent processes by DCs have been reported not to 331 
develop as efficiently into Th2-type effector cells than those generated via an IgE/FcεRI 332 
independent process.
31
 How DCs process antigen and elicit a Th-2 type response is complex, 333 
and might therefore involve other cell types, including platelets that have been implicated in 334 
the innate response and express FcεRI, CD23, and other Immunoglobulin receptors, as well as 335 
toll-like receptors (TLRs).
2
 Indeed, it has been reported that platelet communication with APCs 336 
is regulated by CD40/CD40L interactions, and this might be an important component of DC 337 




communication with T cells in the draining lymph nodes after platelet activation by allergen.
32,33 
338 
Currently, our understanding as to why APCs might require platelets to effect an immune 339 
response is incomplete, but perhaps platelet activation by allergen or pathogens via IgE-340 
dependent processes is a more direct, innate response, with less regulation and control. Two 341 
recent studies report the ability of platelets to modulate the immune response in mouse 342 
models of eosinophilic and allergic airway inflammation.
34,35
 The transfer of human platelets 343 
restored papain-induced airway eosinophilia on an IL-33 deficient background in mice, 344 
supporting a hypothesis that platelets are important in the IL-33 dependent provocation of Th2 345 
immune cells.
34
 Furthermore, the platelet derived Wnt antagonist Dickkopf-1 was reported to 346 
be important for Th2 cell cytokine production in a house dust mite (HDM) model of asthma.
35 
347 
The pathways by which platelets might affect sensitization to allergens in patients with asthma 348 
has not yet been described, but it is of interest that platelets from patients allergic to 349 
Dermatophagoides pteronyssinus have been shown to be activated directly by the specific 350 
allergen, and not activated by other known allergens to which the allergic blood donor was not 351 
sensitized to.
16,18 
Thus, clinical data is suggestive of a interaction between platelets and the 352 
sensitization process. 353 
 354 
It is not understood how induced expression of FcεRI occurs on circulating platelets (Figure 2). 355 
The percentage of platelets that express these receptors remains a small subset of the whole 356 
platelet population, which might suggest that megakaryocytes residing in the bone marrow are 357 
capable of differentiation to ultimately determine the phenotype of subsets of platelets. It is 358 




interesting to note however, that this increase in platelet FcεRI expression is suppressed in mice 359 
subjected to the temporary thrombocytopaenia at the time of allergen sensitization (Figure 2). 360 
The lifespan of murine platelets is between 3-4 days, yet the recording was taken when the 361 
platelet population had fully recovered, suggesting that there is an establishment of immune 362 
memory in a subset of megakaryocytes to continue producing a population of platelets with 363 
increased expression of FcεRI.  364 
 365 
To conclude, the initial processing of antigen in naive animals requires the involvement of 366 
platelets, and leads to an increased production of allergen responsive platelets perhaps 367 
transmitted from megakaryocytes during thrombopoesis, and supports earlier clinical data 368 
reporting the ability of platelets to become activated by specific allergens to which individual 369 
patients with allergy become sensitized to.
16,18,36
 These platelets respond by recruiting to 370 
organs that are exposed to the external environment and migrate to prime resident APCs for an 371 


















Figure Legends  386 
Figure 1. Association of platelets with CD11c
+
 cells in lungs of allergen-sensitized mice. Lungs 387 
from either sham-sensitized or allergen sensitized (OVA) mice were collected at 0, 24, or 48 388 
hours after exposure to aerosolised OVA from day 15. Lung sections were stained for the 389 
presence of CD41
+
 (platelets, red fluorescence) and CD11c+ cells (green fluorescence): 390 
Representation of CD11c+ cell (white arrow) (A); platelets and CD11c
+
 cells localised to airways 391 
in sham sensitized (B) and allergen-sensitized mice (C). Arrows indicate presence of CD11c
+
 392 
cells. A ‘zoomed’ image (using Microsoft Office) represented in the dotted oblong (C) shows 393 
individual platelets (red) attached to the CD11c+ cell (D).  Images photographed using a x40 394 
objective under a Zeiss Axiovert microscope. Images A-D were enhanced to improve 395 
brightness/contrast using Microsoft Powerpoint. The presence of CD11c+ cells was quantified 396 
around airway walls (E). The percentage of CD11c+ cells co-localized with CD41+ platelets was 397 
determined within the airway walls (F). n=4 per group. **P< 0.01, *P< 0.05 compared to sham 398 
control group.  399 
 400 
Figure 2. Induction of temporary thrombocytopaenia during the period of allergen 401 
sensitization and effects on platelet FcERI expression. Mice were administered either a control 402 
IgG antibody, or platelet-depleting anti-GPIbα antibody on days -1 and 6 of the sensitization 403 
procedure to deplete circulating platelets within the time frame of allergen sensitization (OVA) 404 
on days 0 and 7 (A). Tail vein bleeds were conducted on days -1, 0, 9, and 14 to enumerate 405 




circulating platelet and leukocyte numbers (A). Representative histograms show CD41+ 406 
platelets from lysed whole blood (B), FcɛRI expression in sham-sensitized (C), OVA-sensitized + 407 
IgG (D), and OVA-sensitized + anti-GPIbα mice (E). Expression recorded as % of cells expressing 408 
antigen on day 15 in the absence of secondary allergen exposure (F). n=4-5 per group. Data: 409 
means ±SEM. **P< 0.01 versus sham-sensitised control group, ##P<0.01 versus OVA-sensitised 410 
IgG group. 411 
 412 
Figure 3. Effects of temporary thrombocytopaenia during the period of allergen sensitization 413 
on the inflammatory response after subsequent allergen exposure. Mice were administered 414 
either a control IgG antibody, or platelet-depleting anti-GPIbα antibody on days -1 and 6 of the 415 
sensitization procedure to deplete circulating platelets within the time frame of allergen 416 
sensitization (OVA) on days 0 and 7. On days 15, 16, and 17, mice were subsequently exposed 417 
to aerosolized allergen (OVA) for 30 mins/day before BAL was performed on day 18 and 418 
enumerated for eosinophils (B), macrophages (C), neutrophils (D), and lymphocytes (E). n=8-12 419 
per group. Data: means± SEM.  *P< 0.05, **P< 0.01, ***P< 0.001 versus sham-sensitised control 420 
group.  #P< 0.05, ##P< 0.01, versus OVA-sensitised group (OVA+ IgG). 421 
 422 
Figure 4. Effects of temporary thrombocytopaenia during the period of allergen sensitization 423 
on the cytokine expression and IgE titre after subsequent allergen exposure. Mice were 424 
administered either a control IgG antibody, or platelet-depleting anti-GPIbα antibody on days -1 425 
and 6 of the sensitization procedure to deplete circulating platelets within the time frame of 426 




allergen sensitization (OVA) on days 0 and 7. On days 15, 16, and 17, mice were subsequently 427 
exposed to aerosolized allergen (OVA) for 30 mins/day before BAL and blood was harvested on 428 
day 18 for plasma IgE analysis (A), and BAL enumerated for IL-4 (B), IL-5 (C), and IFNγ (D) titres.  429 
n=6-8 per group. Data: means± SEM.  *P< 0.05 versus sham-sensitised control group.  #P< 0.05 430 
versus OVA-sensitised group (OVA+ IgG). 431 
 432 
 433 
Figure 5. Effect of platelets and allergen on DC recruitment. Allergen-sensitized mice had 434 
previously been administered either control IgG or platelet-depleting anti-GPIbα antibody 435 
during the allergen sensitization period, and lungs were harvested at 0 (day 15) and 24 hours 436 
after (day 16) exposure to aerosolized allergen (OVA) for histology or flow cytometry. Lungs 437 
were processed into a single cell suspension and CD11c+ cells were quantified via flow 438 
cytometry using fluorospheres to obtain an accurate count (A) at 0 hours (B), 24 hours (C) post 439 
allergen challenge. n=3-9. Data: means± SEM.  ***P< 0.001 versus sham-sensitized group; and 440 
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A.Blood microsampling 
For blood microsampling to enumerate circulating platelet and leukocyte numbers, mice 
were placed in a heated chamber (37 °C) for 10 minutes before a 1-2 mm cut was made with 
a scalpel blade across the lateral tail vein. Using a micropipette, 2 µl of blood was diluted 
1:100 into stromatol solution for platelet counts, a further 2 µl diluted 1:50 in Turk’s 
solution for leukocyte counts (both using a Neubauer improved haemocytometer). Manual 
counts were made using a Zeiss Axiovert microscope.  
 
B.Immunohistochemistry of lungs. 
At 0h, 24h, and 48h, post one day of allergen challenge on day 15, lungs were recovered 
from terminally anaesthetized mice.  Lungs were inflated with a tracheal cannula with 4% 
PFA and then immersed to fix in 4% PFA for 1 hour. The lungs were then incubated in 10% 
sucrose solution (in PBS) overnight at 4˚C. The sucrose solution was then replaced with 25% 
OCT (in PBS) for 1 hour, and then with 100% OCT for 1 hour. Lungs were then stored at -
80°C, after which they were sectioned (6μm) with a Cryostat and placed on poly-L-lysine 
coated microscope slides.  Tissue sections were stained with primary antibodies to detect 
CD11c+ cells (hamster anti-mouse CD11c Integrin αx chain, HL3, BD Biosciences) and 
Page 57 of 59
For Review Only
platelets (Goat polyclonal IgG Integrin αIIb. k-18, Santa Cruz Biotech), for 2 hours.  Slides 
containing lung sections were then washed and incubated with secondary fluorescent 
antibodies: 1. Donkey anti-goat IgG-Cy3 for 1 hour, before PBS wash followed by 2. Goat-
anti Armenian hamster IgG-FITC for 1 hour. Finally, slides were cover slipped using a photo 
bleaching protecting mountant and stored in the dark at 4°C until required for microscopic 
analysis. 
 
C. Microscopic analysis and Lung morphometry 
 
Lung section slides were analysed under a fluorescent microscope (Zeiss Axioskop) using a 
x100 objective, where CD11c+ cell localisation was measured around airway walls to a depth 
of 50 μm beneath the sub-epithelial basement membrane, in a five field area. CD11c+ cells 
were investigated for platelet co-localisation (CD41+ events) and the extent of those with 
positive results quantified per airway
 
using an image analysis programme (Scion Image; 
National Institutes of Health, Bethesda, MD).  
 
D.Flow cytometric analysis of CD11c+ cells and platelets  
All experiments were analysed on a flow cytometer (FC500 series Beckman Coulter) as 
previously described.
10,16 
Single cell suspensions isolated from lung digestion at 0 and 24 
hours after allergen challenge on day 15 were incubated with the DC marker, anti-CD11c-
fluorescein mAb, in a saturating concentration for 30 minutes at room temperature away 
from direct light.  For quantification of CD11c+ cells, samples were also treated with 
Beckman coulter Flow Count
TM
 fluorosphere beads (Beckman Coulter). Specific gating 
parameters were set up to calibrate for the assayed concentration of the fluorospheres to 
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allow absolute quantification of anti-CD11c-fluorescein positive events. For analysis of 
Platelet FcεRI expression, citrated blood was obtained via cardiac puncture on other groups 
of mice on day 15 in the absence allergen challenge (0 hours). Blood was incubated with 
platelet specific anti-CD41-phycoerythrin mAb and anti-FcεRI-fluorescein mAb in saturating 
concentrations for 30 minutes at room temperature and platelets were gated on size and 
FcεRI positive events were then measured on CD41 positive cells.  
 
E. Quantification of IgE, IL-4, IL-5, and IFN-γ 
Bronchoalveolar lavage samples taken at day 18 were centrifuged at 300 G for 5 minutes 
and supernatants harvested for quantification of IL-4, IL-5, and IFN-γ using specific ELISAs as 
per the manufacturer’s instructions (Duoset, R&D systems). Total IgE was measured in 
plasma samples prepared from citrated blood harvested via cardiac puncture at day 18. A 
murine specific IgE ELISA was used as per the manufacturer’s instructions (BD Pharmingen. 
Primary capture antibody: rat anti-mouse IgE clone R35-72). 
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